NB2013-HR German (GPOH) / Dutch (DCOG) Trial

NCT02641782 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Antibody supply was discontinued by United Therapeutics Corporation.

Conditions

Neuroblastoma

Interventions

DRUG: antibody ch14.18
DRUG: GM-CSF
DRUG: IL-2 i.v.
DRUG: IL-2 s.c.
DRUG: Retinoic acid

Sponsor

University of Cologne